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Abstract
We recently described a method for linkage disequilibrium (LD) mapping, using cladistic analysis of
phased single-nucleotide polymorphism (SNP) haplotypes in a logistic regression framework.
However, haplotypes are often not available and cannot be deduced with certainty from the
unphased genotypes. One possible two-stage approach is to infer the phase of multilocus genotype
data and analyze the resulting haplotypes as if known. Here, haplotypes are inferred using the
expectation-maximization (EM) algorithm and the best-guess phase assignment for each individual
analyzed. However, inferring haplotypes from phase-unknown data is prone to error and this
should be taken into account in the subsequent analysis. An alternative approach is to analyze the
phase-unknown multilocus genotypes themselves. Here we present a generalization of the method
for phase-known haplotype data to the case of unphased SNP genotypes. Our approach is designed
for high-density SNP data, so we opted to analyze the simulated dataset. The marker spacing in the
initial screen was too large for our method to be effective, so we used the answers provided to
request further data in regions around the disease loci and in null regions. Power to detect the
disease loci, accuracy in localizing the true site of the locus, and false-positive error rates are
reported for the inferred-haplotype and unphased genotype methods. For this data, analyzing
inferred haplotypes outperforms analysis of genotypes. As expected, our results suggest that when
there is little or no LD between a disease locus and the flanking region, there will be no chance of
detecting it unless the disease variant itself is genotyped.
Background
Disease-marker association studies of samples of unre-
lated cases and controls have been shown to have the
potential to map all but extremely rare variants contribut-
ing to complex traits [1]. We recently described a method
[2] for linkage disequilibrium (LD) mapping, using cla-
distic analysis of single-nucleotide polymorphism (SNP)
haplotypes in a logistic regression framework, which
allows straightforward incorporation of covariates. Under
the assumption of multiplicative disease risks, the model
is parameterized in terms of the haplotypic log odds of
disease, although the form of the linear predictor can be
generalized to other disease models. Cladistic analyses
take advantage of the expectation that 'similar' haplotypes
in the region flanking a disease locus tend to have similar
risks of disease. Thus, by grouping haplotypes according
to their similarity in terms of the alleles they carry, we
expect to have greater power to detect a susceptibility
locus for complex disease with a high-risk clade of haplo-
types than with the individual haplotypes themselves [2].
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In general, haplotype phase is not known and not deduc-
ible in samples of unrelated individuals. Determining
haplotypes experimentally is too costly to consider for the
large samples that will be needed to detect variants con-
tributing to complex disease. Alternatively, a number of
statistical approaches have been developed to infer haplo-
types and their relative frequencies in a sample and to
assign phase to the multilocus genotypes. Here we use a
simple expectation-maximization (EM) algorithm to infer
haplotypes, in the interests of speed for large datasets. It is
common to employ a two-stage approach of inferring
phase and then analyzing the 'best' haplotype configura-
tion as if it were known with certainty. The disadvantage
of this approach is that we cannot take account of the
uncertainty in the phase assignment process. To overcome
this problem, we propose in this paper a generalization of
our cladistic analysis method for haplotypes to analyze
unphased genotypes directly. We use the Genetic Analysis
Workshop 14 (GAW14) simulated dataset to compare the
analysis of unphased and inferred haplotype analysis in
terms of power and accuracy to locate disease loci.
Methods
Cladistic analysis of haplotypes
Large regions are analyzed using a sliding window of
SNPs, with separate analyses performed in each window.
Phase is estimated in each window independently using
the EM algorithm and for every individual, the resulting
best-guess haplotype pair is included in the analysis as if
it was known to be correct, regardless of its posterior prob-
ability. The pair-wise diversity of the resulting set of hap-
lotypes is based on the number of marker matches within
the window. Ignoring disease status, group-average hierar-
chical clustering techniques are used to construct a dendo-
gram of distinct haplotypes by grouping together
increasingly dissimilar clusters until all haplotypes are
combined into a single clade. Information on the disease
status of the haplotypes is then included, and at each level
of the dendogram a likelihood ratio test is calculated with
the null hypothesis of a random distribution of 'affected'
haplotypes across clusters. The most significant test statis-
tic over all levels of the dendogram, T[MAX], and its exact
p-value calculated from permutations of the case/control
labels, are reported for each window.
Analysis of unphased multilocus genotypes
In practice, phase-known data are generally not available,
so we have generalized our method to analyze multilocus
genotypes directly. The approach is directly analogous to
that used to analyze phase-known haplotypes [2], but
with different weighting used in the pair-wise distance
measure. Consider a sample of individuals typed at M
SNPs, where gim denotes the unphased genotype of indi-
vidual i at locus m, coded as 11, 12, or 22 with 0 for miss-
ing data. Then the pair-wise distance measure is
, such that
where qk[m] denotes the sample's relative frequency of gen-
otype k at locus m. As with the weights used in the haplo-
type measure, this gives more weight to matching rare
alleles at a marker than to matching common alleles.
Our method is designed for high-density SNP data, so we
opted to analyze the GAW14 simulated dataset. The
marker spacing in the initial screen was too large for our
method to be effective, so we used the answers provided
to select regions of interest to request further data. We
chose ten regions of two adjacent packets of markers, con-
taining up to 40 SNPs after the microsatellites were
removed. These regions were chosen to cover the four
main disease loci and the two modifier loci. In addition,
we randomly selected four other regions not containing
disease loci, or null regions, two with background LD
between loci and two without, to check false-positive
error rates. The four regions correspond to packet num-
bers 364–365, 120–121, 178–179 and 287–288.
Cases were selected as the affected founders from each
family, with one case randomly selected from families
with no affected founders, where affection status was
determined from the phenotypes P1, P2, and P3. The four
subpopulations of cases were analyzed separately to allow
for any stratification because the subpopulation of the
controls was unknown. For each subpopulation, all 100
replicates were analyzed individually to assess power,
with each replicate dataset consisting of the selected cases
and the controls for that replicate. Each region was ana-
lyzed using a sliding window of six markers, with separate
analyses performed in each window. To allow for multi-
ple testing, exact regional p-values were calculated for each
region based on the best result seen across all windows
within the region, using 100 random permutations of the
case/control labels. Power was calculated as the propor-
tion of replicate datasets with regional p-value less than
0.05. Accuracy of location was measured as the percentage
of replicate datasets with a regional p-value less than 0.05
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in which the most significant window in the region con-
tained the disease locus.
Results
False-positive error rates
False-positive error rates were estimated over all four sub-
populations for the two analyses by considering the four
null regions, and were calculated as the proportion of data
replicates with an exact regional p-value less than 0.05.
Table 1 contains the mean false-positive error rates for
regions with and without LD, with 95% confidence inter-
vals, for the two analyses. The false-positive rates for both
analyses (Table 1) are consistent with a 5% significance
threshold, even in the presence of background LD in the
region. The rate for the genotype analysis is slightly lower
than the rate for the haplotype analysis regardless of
whether there is background LD in the flanking region.
Power
Table 2 contains the power and accuracy of location (as
the percentage of regionally significant data replicates) of
the two analyses to detect the six disease loci in the four
subpopulations. There are no accuracy estimates for locus
D2 because it is placed on the end of a chromosome and
is not covered by a sliding window. In general, the power
of the haplotype analysis is also greater than the power of
the genotype analysis. The power of the likelihood ratio
test, T[MAX], is affected by its degrees of freedom, which
is determined by the number of different genotypes or
haplotypes observed. Because there will usually be more
multilocus genotypes than haplotypes in a sample, we
expect the genotype analysis to be less powerful. The hap-
lotype analysis also appears to have slightly greater accu-
racy than the genotype analysis in general, although not
when there is little power to detect a locus in a population,
when the accuracy varies considerably. This is due to the
small number of results considered in relation to the
number of windows in the region.
Figure 1 shows the power of the analysis for unphased and
inferred haplotype data for individual windows in the
region around D2 and D4. Both show very localized
peaks, in windows overlapping the true site for D4, and
greater power using inferred haplotypes than using
unphased data. There are no windows overlapping D2.
Discussion
Both methods have good power to detect the D2 locus in
all four subpopulations. This is probably because D2 con-
tributes to all three phenotypes used to identify affected
individuals, but also due to the way the data was simu-
lated for this locus, where the variant was inserted into
haplotypes chosen for their similarity. This is exactly the
scenario that the clustering approach is designed to
exploit. Given the small sample size and the complex
inheritance of the phenotypes, this is very encouraging.
There is also a very localized peak, although it is a little
Table 1: False positive error rates for methods
LD regions (95% CI) No LD regions (95% CI)
Genotypes 0.056 (0.04, 0.072) 0.048 (0.033, 0.062)
Haplotypes 0.064 (0.046, 0.081) 0.054 (0.038, 0.069)
Mean false positive error rates for the two methods, in regions with and without LD, based on false-positive rates in four null regions. Averages 
were taken over all 100 replicate datasets over all four subpopulations.
Table 2: Power of methods for the disease Loci in the subpopulations
Power [Accuracy]
Aipotu Danacaa Karangar NYC
Genoa Haplob Geno Haplo Geno Haplo Geno Haplo
D1 0.06 [33.3] 0.05 [20] 0.06 [16.7] 0.07 [71.4] 0.04 [0] 0.06 [0] 0.07 [0] 0.07 [28.6]
D2 0.30 0.67 0.40 0.89 0.31 0.49 0.36 0.78
D3 0.05 [40] 0.07 [57.1] 0.06 [33.3] 0.04 [25] 0.14 [14.3] 0.17 [64.7] 0.04 [0] 0.09 [55.5]
D4 0.11 [36.4] 0.26 [46.2] 0.03 [0] 0.07 [14.3] 0.29 [31] 0.47 [63.8] 0.08 [37.5] 0.21 [42.9]
M1 0.01 [0] 0.06 [33.3] 0.07 [42.9] 0.16 [68.8] 0.01 [0] 0.14 [57.1] 0.06 [16.7] 0.06 [0]
M2 0.08 [12.5] 0.07 [14.3] 0.02 [0] 0.03 [0] 0.03 [0] 0.04 [0] 0.02 [50] 0.09 [11.1]
Power of unphased and inferred haplotype analyses to detect the four disease loci and two modifier loci in the four subpopulations.
a Geno, unphased
b Haplo, inferredBMC Genetics 2005, 6:S100
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way from the end of the chromosome. It is possible that
this may be a result of LD in the region.
There is some power to detect D4, with the strongest sig-
nal in the Karangar subpopulation, which is also the only
subpopulation in which there is any power to detect D3.
This is again probably due to the phenotypes considered
as affected in the different subpopulations. There is less
power to detect D3 and D4 than for D2, probably because
the haplotypes carrying the variant were chosen by their
frequency rather than by their similarity. This does not fit
the cladistic model, as haplotypes carrying the same muta-
tion could be quite diverse. If the carrier haplotypes are
very diverse, there is no advantage in cladistic analysis.
There is also a more complicated relationship between
phenotype and genotype for the phenotypes affected by
D3 and D4, which may dilute the signal from any one
locus.
D1 is not detected by either method in any of the four sub-
populations. This is probably because the data was simu-
lated with no LD between the disease locus and flanking
markers. As the locus D1 itself was not genotyped, the lack
of LD in the region makes it impossible to detect with
association-based methods.
A small marginal effect was detected by the haplotype
analysis for the modifier locus M1 in the Danacaa and
Karangar populations. This is probably because it converts
the phenotype P2 into P1. In the Danacaa sample individ-
uals with P1 are 'affected' and individuals without P1 are
not 'affected', so converting P2 into P1 will directly influ-
Power of methods for Loci D2 and D4 Figure 1
Power of methods for Loci D2 and D4. The power for each window is plotted at the midpoint of the window in terms of 
marker number within the region. The gap in the lines for D2 is for windows overlapping the end of the chromosome.
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a) the region containing the locus D2, which is located between markers 26 and 27.
b) the region containing the locus D4, which is located between markers 15 and 16.
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ence disease status. A similar effect occurs in the Karangar
subpopulation. There is no marginal effect detected for
the other modifier locus, M2, probably because it does
not directly determine disease status.
Conclusion
Our results suggest that a two-stage strategy of inferring
haplotypes and analyzing the best-guess phase assign-
ment for each individual appears to have more power
than direct analysis of unphased multilocus genotypes.
This is probably due to the smaller number of degrees of
freedom in the test in the haplotype analysis. Haplotypes
were simulated in different ways for the four disease loci,
which affected the power of these methods to detect them.
Cladistic-based analysis performs best when the haplo-
types carrying a disease variant are similar, as simulated
for locus D2, but has some success even when the disease
site does not fit the cladistic model and the haplotypes do
not necessarily fall into useful clades, as for loci D3 and
D4. As expected, when there is no LD in the flanking
region, there is no power to detect association with dis-
ease loci that are not themselves genotyped, as for locus
D1.
A major disadvantage of the inferred haplotype analysis is
the assumption that the inferred phase assignment is cor-
rect, which may result in biased estimates of LD between
loci and inflated false-positive rates for association tests.
Therefore, all possible phase assignments and corre-
sponding probabilities for each individual should be
included in the analysis [3-5]. Here there is little uncer-
tainty in phase assignment, as shown by the correct false-
positive rate for the test on the inferred data, but these
results would not necessarily be expected to apply to
regions with more uncertain haplotype resolution.
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